SIMILAR PATTERNS OF AMINO ACIDS FOR 3H6T_A_CYZA265_1
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1dmu | BGLI RESTRICTIONENDONUCLEASE (Bacillussubtilis) |
PF14562(Endonuc_BglI) | 5 | PRO A 290LEU A 285SER A 239LEU A 35ILE A 288 | None | 1.35A | 3h6tA-1dmuA:undetectable3h6tC-1dmuA:undetectable | 3h6tA-1dmuA:23.813h6tC-1dmuA:23.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1jya | YOPE REGULATOR (Yersiniapseudotuberculosis) |
PF05932(CesT) | 5 | PRO A 94LEU A 74SER A 102LEU A 98ILE A 73 | None | 1.41A | 3h6tA-1jyaA:undetectable3h6tC-1jyaA:undetectable | 3h6tA-1jyaA:17.743h6tC-1jyaA:17.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1m9i | ANNEXIN VI (Homo sapiens) |
PF00191(Annexin) | 5 | SER A 490LEU A 504LEU A 485LYS A 483ILE A 500 | None | 1.41A | 3h6tA-1m9iA:undetectable3h6tC-1m9iA:undetectable | 3h6tA-1m9iA:18.293h6tC-1m9iA:18.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1sax | METHICILLINRESISTANCEREGULATORY PROTEINMECI (Staphylococcusaureus) |
PF03965(Penicillinase_R) | 5 | LYS A 55LEU A 52SER A 71LEU A 72ILE A 8 | None | 1.47A | 3h6tA-1saxA:undetectable3h6tC-1saxA:undetectable | 3h6tA-1saxA:19.383h6tC-1saxA:19.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1upf | URACILPHOSPHORIBOSYLTRANSFERASE (Toxoplasmagondii) |
no annotation | 5 | PRO D 165SER D 116LEU D 196LEU D 73ILE D 233 | None | 1.37A | 3h6tA-1upfD:undetectable3h6tC-1upfD:undetectable | 3h6tA-1upfD:19.153h6tC-1upfD:19.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2lm5 | CALCIUM ANDINTEGRIN-BINDINGPROTEIN 1 (Homo sapiens) |
PF13499(EF-hand_7) | 5 | SER A 145LEU A 144ILE A 153SER A 147LYS A 150 | None | 1.44A | 3h6tA-2lm5A:undetectable3h6tC-2lm5A:undetectable | 3h6tA-2lm5A:21.133h6tC-2lm5A:21.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2qzu | PUTATIVE SULFATASEYIDJ (Bacteroidesfragilis) |
PF00884(Sulfatase) | 5 | PRO A 343LEU A 340LEU A 59ILE A 346SER A 61 | None | 1.43A | 3h6tA-2qzuA:undetectable3h6tC-2qzuA:undetectable | 3h6tA-2qzuA:18.953h6tC-2qzuA:18.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2vn7 | GLUCOAMYLASE (Trichodermareesei) |
PF00686(CBM_20)PF00723(Glyco_hydro_15) | 5 | LEU A 135SER A 139LEU A 142ILE A 158SER A 152 | None | 1.12A | 3h6tA-2vn7A:undetectable3h6tC-2vn7A:undetectable | 3h6tA-2vn7A:18.803h6tC-2vn7A:18.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2zns | GLUTAMATE RECEPTOR,IONOTROPIC KAINATE 1 (Homo sapiens) |
PF10613(Lig_chan-Glu_bd) | 6 | LYS A 516PRO A 517MET A 519LEU A 768LEU A 776LYS A 780 | None | 0.84A | 3h6tA-2znsA:37.23h6tC-2znsA:37.4 | 3h6tA-2znsA:52.873h6tC-2znsA:52.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3kq4 | CUBILIN (Homo sapiens) |
PF00431(CUB) | 5 | SER B1233LEU B1205SER B1250ILE B1257SER B1254 | None | 1.49A | 3h6tA-3kq4B:undetectable3h6tC-3kq4B:undetectable | 3h6tA-3kq4B:20.003h6tC-3kq4B:20.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3nks | PROTOPORPHYRINOGENOXIDASE (Homo sapiens) |
PF01593(Amino_oxidase) | 5 | PRO A 287LEU A 294SER A 292LEU A 306LYS A 429 | None | 1.17A | 3h6tA-3nksA:undetectable3h6tC-3nksA:undetectable | 3h6tA-3nksA:19.963h6tC-3nksA:19.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3qxm | GLUTAMATE RECEPTORIONOTROPIC, KAINATE2 (Homo sapiens) |
PF10613(Lig_chan-Glu_bd) | 6 | LYS A 500PRO A 501MET A 503LEU A 752LEU A 760LYS A 764 | None | 0.88A | 3h6tA-3qxmA:37.13h6tC-3qxmA:37.0 | 3h6tA-3qxmA:52.093h6tC-3qxmA:52.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ryt | PLEXIN-A1 (Mus musculus) |
PF08337(Plexin_cytopl) | 5 | LEU A1688LEU A1799LYS A1794ILE A1466SER A1487 | None | 1.45A | 3h6tA-3rytA:undetectable3h6tC-3rytA:undetectable | 3h6tA-3rytA:18.873h6tC-3rytA:18.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3sdq | ALPHA-BISABOLENESYNTHASE (Abies grandis) |
PF01397(Terpene_synth)PF03936(Terpene_synth_C) | 5 | LYS A 478LEU A 133SER A 129LEU A 127ILE A 182 | None | 1.40A | 3h6tA-3sdqA:undetectable3h6tC-3sdqA:undetectable | 3h6tA-3sdqA:15.303h6tC-3sdqA:15.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3tc3 | UV DAMAGEENDONUCLEASE (Sulfolobusacidocaldarius) |
PF03851(UvdE) | 5 | LYS A 78LEU A 31SER A 35LEU A 38LYS A 42 | None | 1.04A | 3h6tA-3tc3A:undetectable3h6tC-3tc3A:undetectable | 3h6tA-3tc3A:24.543h6tC-3tc3A:24.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3u92 | GLUTAMATE RECEPTOR,IONOTROPIC KAINATE 3 (Rattusnorvegicus) |
PF10613(Lig_chan-Glu_bd) | 6 | LYS A 103PRO A 104MET A 106LEU A 234LEU A 242LYS A 246 | NoneNoneNoneNoneNone ZN A 259 (-3.5A) | 0.76A | 3h6tA-3u92A:37.43h6tC-3u92A:37.3 | 3h6tA-3u92A:52.093h6tC-3u92A:52.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3zm8 | GH26ENDO-BETA-1,4-MANNANASE (Podosporaanserina) |
PF02156(Glyco_hydro_26)PF16990(CBM_35) | 5 | PRO A 292LEU A 294LEU A 142ILE A 223SER A 156 | None | 1.23A | 3h6tA-3zm8A:undetectable3h6tC-3zm8A:undetectable | 3h6tA-3zm8A:19.753h6tC-3zm8A:19.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4bmb | GALECTIN-8 (Homo sapiens) |
PF00337(Gal-bind_lectin) | 5 | PRO A 24LEU A 138LEU A 27ILE A 149SER A 152 | None | 1.44A | 3h6tA-4bmbA:undetectable3h6tC-4bmbA:undetectable | 3h6tA-4bmbA:20.413h6tC-4bmbA:20.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ns4 | ALPHA/BETA HYDROLASEFOLD PROTEIN (Psychrobactercryohalolentis) |
PF00561(Abhydrolase_1) | 5 | SER A 80LEU A 101LEU A 25ILE A 70SER A 22 | None | 1.21A | 3h6tA-4ns4A:undetectable3h6tC-4ns4A:undetectable | 3h6tA-4ns4A:20.363h6tC-4ns4A:20.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ux3 | MITOTIC CHROMOSOMEDETERMINANT-RELATEDPROTEINSTRUCTURALMAINTENANCE OFCHROMOSOMES PROTEIN3 (Saccharomycescerevisiae) |
PF02463(SMC_N)PF04825(Rad21_Rec8_N) | 5 | LYS A1034SER B 54LEU A 179LEU B 68ILE A1030 | None | 0.96A | 3h6tA-4ux3A:undetectable3h6tC-4ux3A:undetectable | 3h6tA-4ux3A:19.783h6tC-4ux3A:19.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4wxj | GLUTAMATE RECEPTORIIB,GLUTAMATERECEPTOR IIB (Drosophilamelanogaster) |
PF10613(Lig_chan-Glu_bd) | 5 | PRO A 112MET A 114LEU A 245SER A 248LEU A 253 | None | 0.79A | 3h6tA-4wxjA:36.73h6tC-4wxjA:36.4 | 3h6tA-4wxjA:40.363h6tC-4wxjA:40.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5dtb | CG3822 (Drosophilamelanogaster) |
PF10613(Lig_chan-Glu_bd) | 5 | PRO A 109MET A 111LEU A 242LEU A 250LYS A 254 | None | 0.56A | 3h6tA-5dtbA:38.43h6tC-5dtbA:39.1 | 3h6tA-5dtbA:54.143h6tC-5dtbA:54.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5gzg | GALECTIN-8 (Homo sapiens) |
PF00337(Gal-bind_lectin) | 5 | PRO A 24LEU A 138LEU A 27ILE A 149SER A 152 | None | 1.41A | 3h6tA-5gzgA:undetectable3h6tC-5gzgA:undetectable | 3h6tA-5gzgA:20.913h6tC-5gzgA:20.91 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5ict | GLUTAMATE RECEPTOR 1 (Drosophilamelanogaster) |
PF10613(Lig_chan-Glu_bd) | 5 | LYS A 110PRO A 111MET A 113LEU A 244LEU A 252 | None | 1.00A | 3h6tA-5ictA:39.23h6tC-5ictA:39.1 | 3h6tA-5ictA:56.343h6tC-5ictA:56.34 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5ikb | GLUTAMATE RECEPTORIONOTROPIC, KAINATE4,GLUTAMATE RECEPTORIONOTROPIC, KAINATE4 (Rattusnorvegicus) |
PF10613(Lig_chan-Glu_bd) | 5 | PRO A 104MET A 106LEU A 235LEU A 243LYS A 247 | None | 0.37A | 3h6tA-5ikbA:36.73h6tC-5ikbA:36.7 | 3h6tA-5ikbA:55.733h6tC-5ikbA:55.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ix1 | MORC FAMILY CW-TYPEZINC FINGER PROTEIN3 (Mus musculus) |
PF07496(zf-CW)PF13589(HATPase_c_3) | 5 | PRO A 146LEU A 135SER A 131ILE A 138SER A 173 | None | 1.21A | 3h6tA-5ix1A:undetectable3h6tC-5ix1A:undetectable | 3h6tA-5ix1A:21.933h6tC-5ix1A:21.93 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5l1b | GLUTAMATE RECEPTOR2,GLUTAMATE RECEPTOR2 (Rattusnorvegicus) |
PF00060(Lig_chan)PF01094(ANF_receptor)PF10613(Lig_chan-Glu_bd) | 7 | LYS A 493PRO A 494MET A 496LEU A 751SER A 754LEU A 759LYS A 763 | None | 0.59A | 3h6tA-5l1bA:22.53h6tC-5l1bA:22.4 | 3h6tA-5l1bA:34.903h6tC-5l1bA:34.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5l1b | GLUTAMATE RECEPTOR2,GLUTAMATE RECEPTOR2 (Rattusnorvegicus) |
PF00060(Lig_chan)PF01094(ANF_receptor)PF10613(Lig_chan-Glu_bd) | 6 | PRO A 494MET A 496SER A 497SER A 754LEU A 759LYS A 763 | None | 0.54A | 3h6tA-5l1bA:22.53h6tC-5l1bA:22.4 | 3h6tA-5l1bA:34.903h6tC-5l1bA:34.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5uje | SBNI PROTEIN (Staphylococcusaureus) |
no annotation | 5 | LEU A 66SER A 65LEU A 27ILE A 40SER A 32 | None | 1.48A | 3h6tA-5ujeA:undetectable3h6tC-5ujeA:undetectable | 3h6tA-5ujeA:16.153h6tC-5ujeA:16.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5wel | CHIMERA OF GLUTAMATERECEPTOR 2, GERMCELL-SPECIFIC GENE1-LIKE PROTEIN (Mus musculus;Rattusnorvegicus) |
PF00060(Lig_chan)PF01094(ANF_receptor)PF07803(GSG-1)PF10613(Lig_chan-Glu_bd) | 8 | LYS A 493PRO A 494MET A 496SER A 497LEU A 751SER A 754LEU A 759LYS A 763 | None | 1.03A | 3h6tA-5welA:32.63h6tC-5welA:32.4 | 3h6tA-5welA:34.033h6tC-5welA:34.03 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5weo | GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNITCHIMERA (Mus musculus;Rattusnorvegicus) |
PF00060(Lig_chan)PF00822(PMP22_Claudin)PF01094(ANF_receptor)PF10613(Lig_chan-Glu_bd) | 5 | LYS A 493MET A 496SER A 497LEU A 751LEU A 759 | NoneCYZ A1302 (-4.3A)CYZ A1302 (-3.2A)NoneNone | 0.69A | 3h6tA-5weoA:25.63h6tC-5weoA:25.4 | 3h6tA-5weoA:34.033h6tC-5weoA:34.03 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5weo | GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNITCHIMERA (Mus musculus;Rattusnorvegicus) |
PF00060(Lig_chan)PF00822(PMP22_Claudin)PF01094(ANF_receptor)PF10613(Lig_chan-Glu_bd) | 5 | LYS A 493MET A 496SER A 497LEU A 759LYS A 763 | NoneCYZ A1302 (-4.3A)CYZ A1302 (-3.2A)NoneCYZ A1302 (-2.9A) | 0.99A | 3h6tA-5weoA:25.63h6tC-5weoA:25.4 | 3h6tA-5weoA:34.033h6tC-5weoA:34.03 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5weo | GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNITCHIMERA (Mus musculus;Rattusnorvegicus) |
PF00060(Lig_chan)PF00822(PMP22_Claudin)PF01094(ANF_receptor)PF10613(Lig_chan-Glu_bd) | 5 | LYS A 493MET A 496SER A 754LEU A 759LYS A 763 | NoneCYZ A1302 (-4.3A)CYZ A1302 ( 4.1A)NoneCYZ A1302 (-2.9A) | 0.97A | 3h6tA-5weoA:25.63h6tC-5weoA:25.4 | 3h6tA-5weoA:34.033h6tC-5weoA:34.03 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5weo | GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNITCHIMERA (Mus musculus;Rattusnorvegicus) |
PF00060(Lig_chan)PF00822(PMP22_Claudin)PF01094(ANF_receptor)PF10613(Lig_chan-Glu_bd) | 5 | LYS A 493PRO A 494MET A 496SER A 497LEU A 751 | NoneCYZ A1302 (-4.5A)CYZ A1302 (-4.3A)CYZ A1302 (-3.2A)None | 0.68A | 3h6tA-5weoA:25.63h6tC-5weoA:25.4 | 3h6tA-5weoA:34.033h6tC-5weoA:34.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5yay | KN MOTIF AND ANKYRINREPEAT DOMAINS 1 (Mus musculus) |
no annotation | 5 | LYS A1259LEU A1293LEU A1246ILE A1255SER A1251 | None | 1.44A | 3h6tA-5yayA:undetectable3h6tC-5yayA:undetectable | 3h6tA-5yayA:16.023h6tC-5yayA:16.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5zal | ENDORIBONUCLEASEDICER (Homo sapiens) |
no annotation | 5 | PRO A1850SER A1852LEU A1841LEU A1735SER A1737 | None | 1.26A | 3h6tA-5zalA:undetectable3h6tC-5zalA:undetectable | 3h6tA-5zalA:13.083h6tC-5zalA:13.08 |